Medical Editor March 23, 2023 FDA advisors vote against effectiveness of Biogen’s ALS drug for rare and aggressive form of the disease – CNBC FDA advisors vote against effectiveness of Biogen’s ALS drug for rare and aggressive form of the disease CNBC